thrombopoietin thpo also known megakaryocyte growth development factor mgdf protein humans encoded thpo gene thrombopoietin glycoprotein hormone produced liver kidney regulates production platelets stimulates production differentiation megakaryocytes bone marrow cells bud large numbers megakaryocytopoiesis cellular development process leads platelet production protein encoded gene humoral growth factor necessary megakaryocyte proliferation maturation well thrombopoiesis protein ligand mlpcmpl product myeloproliferative leukemia virus thrombopoietin gene located long arm chromosome abnormalities gene occur hereditary forms thrombocytosis high platelet count cases leukemia first amino acids protein share homology thrombopoietin produced liver parenchymal cells sinusoidal endothelial cells well kidney proximal convoluted tubule cells small amounts also made striated muscle bone marrow stromal liver production augmented interleukin however liver kidney primary sites thrombopoietin production thrombopoietin regulates differentiation megakaryocytes platelets studies removal thrombopoietin receptor show effects hematopoiesis negative feedback different hormones endocrinology effector regulates hormone directly thrombopoietin bound surface platelets megakaryocytes mpl receptor cd inside platelets gets destroyed inside megakaryocytes gives signal maturation consecutively platelet production bounding hormone cells thereby reduces megakaryocyte exposure therefore rising dropping platelet megakaryocyte concentrations regulate thrombopoietin levels low platelets megakaryocytes lead higher degree thrombopoietin exposure undifferentiated bone marrow cells leading differentiation megakaryocytes maturation cells hand high platelet megakaryocyte concentrations lead thrombopoetin destruction thus less availability thrombopoietin bone marrow tpo like epo plays role brain development promotes apoptosis newly generated neurons effect counteracted epo despite numerous trials thrombopoietin found useful therapeutically theoretical uses include procurement platelets recovery platelet counts myelosuppressive trials modified recombinant form megakaryocyte growth differentiation factor mgdf stopped healthy volunteers developed autoantibodies endogenous thrombopoietin developed romiplostim eltrombopag structurally different compounds stimulate pathway used quadrivalent peptide analogue investigated well several smallmolecule several nonpeptide ligands cmpl act thrombopoietin thrombopoietin cloned five independent teams identification function hypothesized much years linked cell surface receptor cmpl older publications thrombopoietin described cmpl ligand agent binds cmpl molecule thrombopoietin one class hematopoietic human thrombopoietin functional domain complexed neutralizing antibody fab human thrombopoietin functional domain complexed neutralizing antibody fab httpsenwikipediaorgwikithrombopoietin